Handheld Ultrasound Devices Market By Product Type (Wireless Devices, Wired Devices); By Application (Cardiology, Obstetrics and Gynecology, Emergency Medicine, Musculoskeletal, Urology, Others); By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Military and Disaster-Relief Units); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Global Handheld Ultrasound Market to Reach USD 4.57 Billion by 2032, Driven by AI, Portability and Point-of-Care Adoption

The Global Handheld Ultrasound Devices Market was valued at USD 2.31 billion in 2025 and is projected to reach USD 4.57 billion by 2032, growing at a CAGR of 10.2%, according to Strategic Market Research.

 

Handheld ultrasound devices are compact imaging systems that connect to smartphones, tablets, or dedicated displays. They produce real-time scans beside the patient, allowing clinicians to assess focused clinical questions without first transferring the patient to a radiology department.

 

Portability, lower acquisition costs than full-sized systems, and faster clinical decision-making are supporting adoption in emergency departments, intensive-care units, ambulances, rural clinics, physician practices, and mobile-care programs. Depending on the probe and software, one system can support cardiac, abdominal, vascular, obstetric, lung, and musculoskeletal examinations.

 

The market includes diagnostic imaging, monitoring, and guidance during selected procedures. It excludes therapeutic ultrasound, lithotripsy, tissue-ablation equipment, fetal Doppler-only products, dedicated bladder scanners, and larger cart-based systems.

 

Commercial competition is also shifting beyond hardware. Hospitals increasingly evaluate handheld ultrasound as a platform combining probes, artificial-intelligence applications, cloud storage, tele-ultrasound, image management, clinical documentation, training, and device-fleet administration. Hardware creates initial and replacement revenue, while software subscriptions, AI modules, service, and workflow integration provide recurring income.

 

Handheld Ultrasound Devices: Market Growth, Applications and Technology Trends

Handheld ultrasound became a more visible part of point-of-care imaging during 2025–2026 as healthcare providers sought systems that could be used at the bedside, during patient transport, or in locations without conventional imaging infrastructure.

Products such as Butterfly iQ3, GE HealthCare Vscan Air, Philips Lumify, Mindray TE Air, Clarius HD3, and Exo Iris are used across emergency medicine, critical care, anesthesiology, cardiology, obstetrics, primary care, and procedure-based specialties.

These systems complement rather than fully replace cart-based ultrasound. Full-sized equipment continues to serve detailed echocardiography, advanced radiology, high-volume imaging, and examinations requiring specialized probes. Handheld devices are commercially strongest when clinicians need a rapid answer, repeated bedside monitoring, or real-time procedural guidance.

Clinical use is extending beyond hospitals into ambulances, rural facilities, community practices, sports-medicine clinics, and remotely supported care. Common applications include identifying internal bleeding or fluid accumulation, evaluating cardiac and lung function, assessing abdominal organs, guiding vascular access, and supporting injections or musculoskeletal examinations.

Cloud connectivity and tele-ultrasound allow images to be shared with specialists in another location. This can extend imaging access where radiologists, cardiologists, or trained sonographers are unavailable. Electronic-record integration and DICOM connectivity also improve documentation, image storage, quality review, and institutional oversight.

Industry estimates supplied for this analysis indicate that approximately 800 million to 1 billion ultrasound examinations are performed globally each year. The United States accounts for about 150–180 million annual scans, while Europe performs approximately 250 million. These totals include handheld, portable, and cart-based equipment, but they illustrate the size of the diagnostic workflow into which handheld systems are entering.

 

Large Clinical Pathways Support Repeated Imaging Demand

The market is connected to pregnancy, heart failure, respiratory illness, trauma, venous thromboembolism, kidney stones, vascular access, and musculoskeletal conditions. One scanner can support repeated examinations across numerous patients and clinical departments.

The United States recorded approximately 3.63 million live births in 2024, while the estimated global total was about 134.3 million. Obstetric care can generate several imaging events, including early assessment, gestational-age estimation, fetal-presentation checks, emergency evaluation, and perioperative assessment.

Nearly 6.7 million U.S. adults have heart failure, compared with approximately 55.5 million prevalent cases globally. Focused cardiac and lung ultrasound can support assessment of ventricular function, congestion, fluid status, and pericardial effusion in emergency care, intensive-care units, hospital wards, and cardiology practices.

The global burden of non-COVID lower respiratory infection was estimated at 344 million episodes in 2021. Lung ultrasound can help assess pneumonia, pleural effusion, pulmonary edema, pneumothorax, and other causes of respiratory deterioration. Bedside availability and the ability to repeat examinations without radiation exposure support its use in acute-care environments.

U.S. emergency departments recorded approximately 43.5 million injury-related visits in 2022, while road crashes cause an estimated 20–50 million nonfatal injuries globally each year. Handheld systems can support rapid trauma assessment for internal bleeding, pericardial fluid, and thoracic injury before definitive imaging or surgery.

Venous thromboembolism affects up to 900,000 people annually in the United States and nearly 10 million worldwide. Compression ultrasound supports evaluation of suspected deep-vein thrombosis, while focused cardiac assessment can assist in severe pulmonary-embolism presentations.

Kidney-stone pathways add further demand. Approximately 11% of U.S. men and 6% of U.S. women experience a kidney stone during their lifetime, while global incidence was estimated at approximately 105.98 million cases in 2021.

These patient populations overlap and should not be combined into one addressable-market total. Device demand is better evaluated through trained users, clinical departments, installed systems, scans per device, procedure volumes, and software subscriptions.

 

Role Across Diagnosis, Treatment and Procedures

Handheld ultrasound is primarily a diagnostic and monitoring product, but its findings can directly affect treatment and surgical decisions. In heart failure and respiratory care, serial examinations can influence fluid management, medication, oxygen support, escalation, or discharge. In trauma, focused imaging can determine whether a patient needs surgery, advanced imaging, observation, or transfer.

The device has a more direct role in procedural guidance. It is used during central and peripheral vascular access, regional anesthesia, aspiration, drainage, injections, biopsy, and selected pain-management procedures.

Approximately 5 million central venous catheters are inserted annually in the United States and about 27 million worldwide. Ultrasound guidance can improve placement success, reduce repeat attempts, and lower mechanical complications, connecting procurement to both patient safety and procedure efficiency.

The obstetric pathway also creates procedural demand. Approximately 1.16 million cesarean deliveries were calculated from 2023 U.S. birth data and the reported cesarean rate. Handheld imaging can support fetal presentation, placental location, gestational assessment, and perioperative evaluation in selected cases.

 

Artificial Intelligence Is Reshaping Competition

Artificial intelligence is becoming a major competitive factor because image quality depends heavily on the operator. AI can guide probe positioning, assist image acquisition, automate measurements, and simplify tasks such as cardiac calculations, B-line counting, bladder-volume estimation, and gestational-age assessment.

Butterfly iQ3 uses semiconductor-based ultrasound technology and a single multipurpose probe for whole-body imaging. GE HealthCare’s Vscan Air uses a wireless dual-sided probe that combines shallow and deep imaging capabilities. These platforms reflect two different strategies: a software-controlled multipurpose probe and a dual-ended system based on specialized transducers.

Butterfly Network received FDA clearance in 2026 for an automated gestational-age tool integrated with its handheld platform. Exo has introduced FDA-cleared software for cardiac and lung assessment, while GE HealthCare offers AI-assisted cardiac image acquisition with Vscan Air SL.

These developments expand software revenue and make handheld imaging more accessible to clinicians who are not specialist sonographers. However, health systems still require training, credentialing, image review, clinical documentation, maintenance, and quality assurance. Vendors that combine imaging hardware with education, guided scanning, reporting, and enterprise oversight are gaining a stronger competitive position.

 

U.S. Demand Is Moving Toward Enterprise Deployment

Early U.S. adoption often involved individual clinicians purchasing probes. Larger opportunities now involve departmental contracts and health-system deployments that connect handheld devices with image review, electronic records, billing, user credentialing, and quality-assurance systems.

Hospitals can deploy one platform across emergency medicine, intensive care, anesthesiology, cardiology, oncology, dialysis, obstetrics, and surgical services. This raises utilization per device and strengthens the case for multi-unit procurement.

Purchasing decisions increasingly extend beyond hardware price. Buyers consider clinical coverage, image consistency, software fees, cybersecurity, device management, training, documentation, image archiving, and compatibility with existing hospital systems.

 

Handheld Ultrasound Devices Market Segmentation Analysis

Strategic Market Research estimates each segment independently against the USD 2.31 billion global market in 2025 and the USD 4.57 billion forecast for 2032.

Segmentation by Product Type

Wireless devices led the market with a 65.0% share in 2025, generating approximately USD 1.502 billion. The segment is projected to expand at a CAGR of 11.7% and reach USD 3.258 billion by 2032.

Wireless systems support easier movement between beds, examination rooms, ambulances, and outpatient settings. Their growth is also connected to improved batteries, secure connectivity, infection-control requirements, and cloud-based image transfer. Products such as GE HealthCare Vscan Air, Mindray TE Air, and Clarius HD3 reflect the broader transition toward cable-free imaging.

Wired devices accounted for the remaining 35.0% share, equivalent to USD 0.809 billion in 2025. The segment is forecast to grow at a CAGR of 7.2% and reach USD 1.315 billion by 2032.

Wired products continue to appeal to clinicians seeking stable connectivity, predictable performance, and a lower equipment cost. Growth is slower because cables can restrict movement and make the systems less convenient for multi-room and mobile deployment.

 

Segmentation by Application

Cardiology was the largest application, accounting for 26.0% of market revenue in 2025, or approximately USD 0.601 billion. The segment is projected to grow at a CAGR of 10.4% and reach USD 1.201 billion by 2032.

Demand is supported by focused assessment of cardiac function, congestion, pericardial fluid, and hemodynamic instability. AI-guided cardiac acquisition is also allowing emergency and critical-care clinicians to capture more standardized views.

Obstetrics and gynecology held a 23.0% share in 2025, generating approximately USD 0.531 billion. The segment is forecast to reach USD 1.042 billion by 2032, expanding at a CAGR of 10.1%.

Growth is linked to pregnancy assessment, fetal presentation, gestational-age estimation, emergency obstetric care, and maternal-health programs in regions with limited access to conventional imaging.

Emergency medicine represented 18.0% of the market in 2025, equivalent to USD 0.416 billion. It is projected to be the fastest-growing application, expanding at a CAGR of 12.1% to reach USD 0.925 billion by 2032.

Handheld systems are used in trauma, shock, cardiac arrest, respiratory distress, vascular access, suspected deep-vein thrombosis, and acute abdominal assessment. Emergency departments also generate repeated examinations during the same episode of care.

Musculoskeletal applications accounted for a 14.0% share, generating approximately USD 0.323 billion in 2025. Revenue is projected to reach USD 0.671 billion by 2032, growing at a CAGR of 11.0%.

Demand is expanding in sports medicine, orthopedics, pain management, rehabilitation, and image-guided injections. These specialties frequently operate outside hospital radiology departments, creating opportunities for clinician-owned systems.

Urology represented 8.0% of market revenue in 2025, or approximately USD 0.185 billion. The segment is forecast to grow at a CAGR of 7.8% and reach USD 0.313 billion by 2032.

The principal uses include assessment of hydronephrosis, urinary obstruction, bladder conditions, and selected kidney-stone presentations. Growth is moderated by competition from conventional abdominal imaging and dedicated bladder scanners.

Other applications accounted for the remaining 11.0% share, equivalent to USD 0.254 billion in 2025. Revenue is projected to reach USD 0.419 billion by 2032, expanding at a CAGR of 7.4%. This category includes abdominal assessment, primary care, pain medicine, aesthetic procedures, and selected research uses.

 

Segmentation by End User

Hospitals led the market with a 49.0% share in 2025, generating approximately USD 1.132 billion. Hospital revenue is projected to reach USD 2.069 billion by 2032, expanding at a CAGR of 9.0%.

Hospitals use handheld systems across emergency care, intensive care, anesthesiology, cardiology, oncology, dialysis, obstetrics, and surgery. Large contracts increasingly include software, image archiving, fleet management, credentialing, and quality-assurance services.

Clinics accounted for 24.0% of revenue in 2025, equivalent to USD 0.554 billion. The segment is forecast to grow at a CAGR of 10.4% and reach USD 1.108 billion by 2032.

Cardiology, primary-care, obstetric, sports-medicine, and pain-management clinics can add imaging capabilities without purchasing a full-sized system. Adoption is influenced by purchase price, training requirements, software fees, and reimbursement.

Ambulatory surgical centers held a 12.0% share, generating approximately USD 0.277 billion in 2025. Revenue is expected to reach USD 0.576 billion by 2032, growing at an 11.0% CAGR.

Demand is linked to vascular access, regional anesthesia, injections, drainage, and perioperative assessment. A single device can be shared across several procedure rooms, improving utilization.

Home care settings accounted for a 9.0% market share in 2025, equivalent to USD 0.208 billion. This is projected to be the fastest-growing end-user segment, expanding at a CAGR of 13.7% and reaching USD 0.511 billion by 2032.

Growth is supported by home-based cardiac and pulmonary assessment, community care, remote specialist review, and simplified scanning workflows.

Military and disaster-relief units represented 6.0% of market revenue in 2025, or approximately USD 0.139 billion. The segment is forecast to grow at a CAGR of 12.0% and reach USD 0.306 billion by 2032.

Portability, battery operation, rapid trauma assessment, and use in remote environments make handheld ultrasound suitable for military medicine, field hospitals, rescue operations, and disaster-response programs.

 

Segmentation by Geography

North America led the global market with a 38.0% share in 2025, representing approximately USD 0.878 billion. The region is projected to reach USD 1.625 billion by 2032, expanding at a CAGR of 9.2%.

The region benefits from established point-of-care ultrasound practices, hospital technology spending, clinician training, AI development, and the presence of major manufacturers. Growth is increasingly linked to enterprise deployments, procedural applications, and software subscriptions.

Europe accounted for 27.0% of the global market in 2025, equivalent to approximately USD 0.624 billion. Revenue is projected to reach USD 1.162 billion by 2032, growing at a CAGR of 9.3%.

Demand is supported by established ultrasound use in emergency care, obstetrics, primary care, cardiology, and specialist practices. Adoption varies by country because reimbursement, procurement, and training requirements differ across healthcare systems.

Asia-Pacific represented 25.0% of revenue in 2025, generating approximately USD 0.578 billion. It is forecast to be the fastest-growing region, expanding at a CAGR of 12.4% and reaching USD 1.309 billion by 2032.

Growth is supported by a large patient population, uneven access to conventional imaging, hospital investment, rural healthcare programs, and medical-device manufacturing in China, Japan, South Korea, India, and Southeast Asia.

Latin America held a 6.0% share in 2025, equivalent to approximately USD 0.139 billion. The market is projected to grow at a CAGR of 10.5% and reach USD 0.279 billion by 2032.

Adoption is concentrated in private hospitals, emergency departments, maternal-health services, and urban clinics. Distributor coverage, imported-device costs, currency conditions, and training availability affect expansion.

The Middle East and Africa accounted for the remaining 4.0% share, generating approximately USD 0.092 billion in 2025. Revenue is forecast to reach USD 0.198 billion by 2032, growing at a CAGR of 11.5%.

Maternal care, emergency medicine, humanitarian healthcare, rural diagnosis, and mobile clinics create the largest opportunities. Market development depends on affordable equipment, maintenance, clinician training, charging infrastructure, and remote specialist support.

 

Adoption Indicators and Training Requirements

Rivanna reported that handheld systems represented 3.1% of the wider ultrasound market, compared with 29.8% for portable systems and 67.8% for cart or trolley equipment. It also reported that search interest increased 488% between 2010 and 2025.

Reported point-of-care adoption was highest in critical care at 93%, emergency medicine at 89%, and anesthesiology at 83%. These percentages indicate strong clinical familiarity, although adoption definitions may include handheld, portable, and cart-based point-of-care systems.

A Clarius survey of 687 physicians in the United States, United Kingdom, and Canada found that 85% associated ultrasound with improved patient outcomes, 86% already had access to a system, and 87% intended to purchase or upgrade equipment.

Among respondents with ultrasound equipment, 51% used compact or console systems, 37% used carts, and 12% used handheld devices. Training was the leading barrier among physicians without access, showing that simpler equipment and AI guidance still need to be supported by structured education and clinical governance.

 

Competitive Landscape

GE HealthCare competes through the Vscan family and reported more than 50,000 Vscan systems in clinicians’ hands as of 2023, with an estimated impact on more than 100 million patients. Philips participates through Lumify, while Butterfly Network combines a whole-body probe with enterprise workflow software, AI applications, and education.

Clarius follows a specialty-focused wireless-scanner strategy and reported availability in more than 70 countries and almost 7 million cumulative scans. Exo positions Iris around integrated hardware, workflow, and on-device AI. Mindray is expanding the TE Air portfolio, while Healcerion competes through the SONON family.

ASUS entered the U.S. market after the LU800 series received FDA 510(k) clearance in December 2025. The participation of a major electronics company illustrates how mobile computing, software, and connected-device capabilities are attracting competitors beyond traditional medical-imaging manufacturers.

Competition will increasingly depend on clinical coverage, image consistency, AI validation, software economics, training support, regulatory reach, interoperability, and the ability to serve both individual practitioners and large healthcare organizations.

 

Market Outlook

Handheld ultrasound is progressing from an individually purchased probe toward a managed point-of-care imaging platform. The strongest adoption will occur where the device supports a defined clinical decision or procedure, fits documentation requirements, and can be governed across a department or healthcare system.

In the United States, enterprise integration, AI-assisted acquisition, procedural use, reimbursement documentation, and quality assurance will shape purchasing. Internationally, distribution, training, maternal-health programs, emergency-care access, and operation in resource-constrained settings will carry greater weight.

 

Handheld Ultrasound Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 2.31 Billion
Revenue Forecast in 2032	USD 4.57 Billion
Overall Growth Rate	CAGR of 10.2% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product Type, By Application, By End User, By Geography
By Product Type	Wireless Devices, Wired Devices
By Application	Cardiology, Obstetrics and Gynecology, Emergency Medicine, Musculoskeletal, Urology, Others
By End User	Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Military and Disaster-Relief Units
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Rising adoption of point-of-care imaging across emergency, critical-care, and procedural settings; increasing demand for portable and lower-cost diagnostic systems; wider integration of AI-assisted image acquisition and automated measurements; expansion of cloud connectivity, tele-ultrasound, and enterprise imaging workflows; growing use in rural healthcare, home care, ambulances, and disaster-response programs
Customization Option	Available upon request